abstract |
Described herein are prostate-specific membrane antigen (PSMA)-binding conjugates for the delivery of therapeutic, diagnostic, and imaging agents. Also described herein are pharmaceutical compositions comprising the same and methods of using the conjugates and compositions. Also described are methods for making the conjugates and compositions comprising the same. |